Cargando…
Bladder rupture after pembrolizumab immunotherapy for bladder cancer: a case report
Pembrolizumab is a promising checkpoint inhibitor for advanced urothelial carcinoma. Like other immunotherapies, it can cause rare immune-related adverse events. The spontaneous rupture of the urinary bladder after the intravenous injection of pembrolizumab is rare and has not been reported. Here, w...
Autores principales: | Badheeb, Ahmed, Alkhanbashi, Omar, Rakrouki, Slah, Mahmood, Tahir, Alqannas, Mashhoor, Badheeb, Mohamed, Ahmed, Faisal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The African Field Epidemiology Network
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379440/ https://www.ncbi.nlm.nih.gov/pubmed/36034031 http://dx.doi.org/10.11604/pamj.2022.42.98.33911 |
Ejemplares similares
-
Ewing's Sarcoma (Primitive Neuroectodermal Tumor) of Seminal Vesicles: A Case Report
por: Badheeb, Ahmed M, et al.
Publicado: (2022) -
Metastasis of colorectal adenocarcinoma to the right ventricle in a young man: a case report
por: Badheeb, Ahmed, et al.
Publicado: (2023) -
Primary pulmonary leiomyosarcoma with coexistent pulmonary aspergillosis: a case report
por: Badheeb, Ahmed, et al.
Publicado: (2022) -
Prevalence of osteoporosis and osteopenia among cancer patients and its risk factors: a retrospective monocentric study
por: Badheeb, Ahmed, et al.
Publicado: (2023) -
Clinical and Therapeutic Profile of Non-Hodgkin’s Lymphoma: A Retrospective Study From a Najran Oncology Center
por: Badheeb, Ahmed M, et al.
Publicado: (2023)